A carregar...
116.2 Discovery and Development of Novel M1 and M4 PAMs for the Treatment of Schizophrenia.
Background: Multiple lines of evidence indicate that development of selective positive allosteric modulators (PAMs) of the M1 and M4 muscarinic acetylcholine receptor subtypes (mAChR) represent important novel therapeutic approaches for the complex symptoms associated schizophrenia. Over the last de...
Na minha lista:
| Publicado no: | Schizophr Bull |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475619/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx021.164 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|